BridgeMD
New treatment option for Recession, Gingival
Official title Comparison of Two Methods of Covering a Single Lower Front Tooth With Receded Gums
ClinicalTrials.gov ID: NCT06037161
What this study is testing
- What it's testing
- The primary objective of this randomized clinical trial is to compare the mean root coverage achieved with Coronally Advanced Flap (CAF) + Connective Tissue Graft (CTG) (control) to Gingival Pedicle Split Thickness flap (GPST) + CTG (test) for the treatment of isolated gingival recession defects in mandibular incisors. The secondary objectives are to compare the percentage of complete root coverage and keratinized tissue gain between the two techniques.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Males and females of \> 18 years of age
- Single Cairo's RT1 (Recession Type 1) and RT2 ( Recession Type 2) recession defects (≥3 mm in depth) in mandibular anterior teeth (Incisors).
- Presence of identifiable cemento-enamel junction (CEJ)
- Presence of a step ≤1 mm at the CEJ level and/or the presence of a root abrasion, but with an identifiable CEJ, will be accepted
- Periodontally and systemically healthy patients
You likely can't join if
- Vaping, chewing tobacco or smoking \> 10 cigarettes per day
- Uncontrolled Diabetes Mellitus (HbA1c \> 7)
- Pregnancy and Lactation
- Diseases affecting connective tissue metabolism
- Long-term steroid use
- Recession defects associated with caries
See the full eligibility criteria
- Males and females of \> 18 years of age
- Single Cairo's RT1 (Recession Type 1) and RT2 ( Recession Type 2) recession defects (≥3 mm in depth) in mandibular anterior teeth (Incisors).
- Presence of identifiable cemento-enamel junction (CEJ)
- Presence of a step ≤1 mm at the CEJ level and/or the presence of a root abrasion, but with an identifiable CEJ, will be accepted
- Periodontally and systemically healthy patients
- No contraindications for periodontal surgery and not taking medications known to interfere with periodontal tissue health or healing; and no prior periodontal surgery on the involved sites
- Vaping, chewing tobacco or smoking \> 10 cigarettes per day
- Uncontrolled Diabetes Mellitus (HbA1c \> 7)
- Pregnancy and Lactation
- Diseases affecting connective tissue metabolism
- Long-term steroid use
- Recession defects associated with caries
- Teeth associated with pulpal pathology
The study team makes the final eligibility decision.
Where it's taking place
- Cleveland, Ohio, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cleveland, Ohio, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.